Semarion is accelerating in vitro drug discovery by tackling adherent cell assays, a fundamental bottleneck for rapid data generation. Our proprietary SemaCyte platform leverages novel materials physics to mobilise and barcode adherent cells, shifting the paradigm of how cell models are handled, stored, and assayed. With a 10x increase in throughput and a 6x cost reduction for biopharma workflows, we're pioneering the next generation of cell biology automation.
